Vasilopoulou, F., Rodríguez-Arévalo, S., Bagan Polonio, A., Escolano Mirón, C., Griñán Ferré, C., & Pallàs i Llibería, M. (2021). Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: A Comparative study with donepezil.
Citação norma ChicagoVasilopoulou, Foteini, Sergio Rodríguez-Arévalo, Andrea Bagan Polonio, Carmen Escolano Mirón, Christian Griñán Ferré, e Mercè Pallàs i Llibería. Disease-modifying Treatment With I2 Imidazoline Receptor Ligand LSL60101 in an Alzheimer's Disease Mouse Model: A Comparative Study With Donepezil. 2021.
Citação norma MLAVasilopoulou, Foteini, et al. Disease-modifying Treatment With I2 Imidazoline Receptor Ligand LSL60101 in an Alzheimer's Disease Mouse Model: A Comparative Study With Donepezil. 2021.